Search Results - "MARKS, Leonard S"

Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review by Valerio, Massimo, Donaldson, Ian, Emberton, Mark, Ehdaie, Behfar, Hadaschik, Boris A, Marks, Leonard S, Mozer, Pierre, Rastinehad, Ardeshir R, Ahmed, Hashim U

“…Abstract Context The current standard for diagnosing prostate cancer in men at risk relies on a transrectal ultrasound–guided biopsy test that is blind to the…”
Get full text

Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device by Sonn, Geoffrey A, Natarajan, Shyam, Margolis, Daniel J A, MacAiran, Malu, Lieu, Patricia, Huang, Jiaoti, Dorey, Frederick J, Marks, Leonard S

“…Targeted biopsy of lesions identified on magnetic resonance imaging may enhance the detection of clinically relevant prostate cancers. We evaluated prostate…”
Get more information

The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer by Loeb, Stacy, Sanda, Martin G, Broyles, Dennis L, Shin, Sanghyuk S, Bangma, Chris H, Wei, John T, Partin, Alan W, Klee, George G, Slawin, Kevin M, Marks, Leonard S, van Schaik, Ron H.N, Chan, Daniel W, Sokoll, Lori J, Cruz, Amabelle B, Mizrahi, Isaac A, Catalona, William J

“…Purpose The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now…”
Get full text

Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? by Hu, Jim C, Chang, Edward, Natarajan, Shyam, Margolis, Daniel J, Macairan, Malu, Lieu, Patricia, Huang, Jiaoti, Sonn, Geoffrey, Dorey, Frederick J, Marks, Leonard S

“…Established in 1994, the Epstein histological criteria (Gleason score 6 or less, 2 or fewer cores positive and 50% or less of any core) have been widely used…”
Get more information

Target detection: Magnetic resonance imaging-ultrasound fusion–guided prostate biopsy by Sonn, Geoffrey A., M.D, Margolis, Daniel J., M.D, Marks, Leonard S., M.D

“…Abstract Recent advances in multiparametric magnetic resonance imaging (MRI) have enabled image-guided detection of prostate cancer. Fusion of MRI with…”
Get full text

The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer by Tan, Hung-Jui, Marks, Leonard S, Hoyt, Michael A, Kwan, Lorna, Filson, Christopher P, Macairan, Malu, Lieu, Patricia, Litwin, Mark S, Stanton, Annette L

“…Purpose Anxiety may serve as a major barrier to participation in active surveillance. Intolerance of uncertainty, that is the tendency to perceive the…”
Get full text

Clinical application of a 3D ultrasound-guided prostate biopsy system by Natarajan, Shyam, M.S, Marks, Leonard S., M.D, Margolis, Daniel J.A., M.D, Huang, Jiaoti, M.D., Ph.D, Macairan, Maria Luz, M.D, Lieu, Patricia, Fenster, Aaron, Ph.D

“…Abstract Objectives Prostate biopsy (Bx) has for 3 decades been performed in a systematic, but blind fashion using 2D ultrasound (US). Herein is described the…”
Get full text

Partial Gland Treatment of Prostate Cancer Using High-Intensity Focused Ultrasound in the Primary and Salvage Settings: A Systematic Review by Golan, Ron, Bernstein, Adrien N., McClure, Timothy D., Sedrakyan, Art, Patel, Neal A., Parekh, Dipen J., Marks, Leonard S., Hu, Jim C.

“…Advances in prostate imaging, biopsy and ablative technologies have been accompanied by growing enthusiasm for partial gland ablation, particularly using…”
Get full text

Harnessing clinical annotations to improve deep learning performance in prostate segmentation by Sarma, Karthik V, Raman, Alex G, Dhinagar, Nikhil J, Priester, Alan M, Harmon, Stephanie, Sanford, Thomas, Mehralivand, Sherif, Turkbey, Baris, Marks, Leonard S, Raman, Steven S, Speier, William, Arnold, Corey W

“…Developing large-scale datasets with research-quality annotations is challenging due to the high cost of refining clinically generated markup into high…”
Get full text

APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer by Groskopf, Jack, Aubin, Sheila M.J, Deras, Ina Lim, Blase, Amy, Bodrug, Sharon, Clark, Craig, Brentano, Steven, Mathis, Jeannette, Pham, Jimmykim, Meyer, Troels, Cass, Michelle, Hodge, Petrea, Macairan, Maria Luz, Marks, Leonard S, Rittenhouse, Harry

“…Prostate cancer gene 3 (PCA3) encodes a prostate-specific mRNA that has shown promise as a prostate cancer diagnostic tool. This report describes the…”
Get full text

Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay by Hansen, Jens, Auprich, Marco, Ahyai, Sascha A, de la Taille, Alexandre, van Poppel, Hendrik, Marberger, Michael, Stenzl, Arnulf, Mulders, Peter F.A, Huland, Hartwig, Fisch, Margit, Abbou, Clement-Claude, Schalken, Jack A, Fradet, Yves, Marks, Leonard S, Ellis, William, Partin, Alan W, Pummer, Karl, Graefen, Markus, Haese, Alexander, Walz, Jochen, Briganti, Alberto, Shariat, Shahrokh F, Chun, Felix K

“…Abstract Background Urinary prostate cancer antigen 3 (PCA3) assay in combination with established clinical risk factors improves the identification of men at…”
Get full text

Prostate Cancer Gene 3 ( PCA3 ): Development and Internal Validation of a Novel Biopsy Nomogram by Chun, Felix K, de la Taille, Alexandre, van Poppel, Hendrik, Marberger, Michael, Stenzl, Arnulf, Mulders, Peter F.A, Huland, Hartwig, Abbou, Clement-Claude, Stillebroer, Alexander B, van Gils, Martijn P.M.Q, Schalken, Jack A, Fradet, Yves, Marks, Leonard S, Ellis, William, Partin, Alan W, Haese, Alexander

“…Abstract Background Urinary prostate cancer gene 3 ( PCA3 ) represents a promising novel marker of prostate cancer detection. Objective To test whether urinary…”
Get full text

Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification by Liu, Yongkai, Zheng, Haoxin, Liang, Zhengrong, Miao, Qi, Brisbane, Wayne G, Marks, Leonard S, Raman, Steven S, Reiter, Robert E, Yang, Guang, Sung, Kyunghyun

“…The current standardized scheme for interpreting MRI requires a high level of expertise and exhibits a significant degree of inter-reader and intra-reader…”
Get full text

Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging by Topoozian, Mark, Calais, Jeremie, Felker, Ely, Sisk, Anthony, Gonzalez, Samantha, Lee, Sean J., Marks, Leonard S.

“…Focal therapy of prostate cancer (PCa) is currently of great interest, but a metric of success. other than biopsy, is not yet available. In a patient with a…”
Get full text

Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes by Aker, Mamdouh N., Brisbane, Wayne G., Kwan, Lorna, Gonzalez, Samantha, Priester, Alan M., Kinnaird, Adam, Delfin, Merdie K., Felker, Ely, Sisk, Anthony E., Kuppermann, David, Marks, Leonard S.

“…Background Partial gland ablation (PGA) is a new option for treatment of prostate cancer (PCa). Cryotherapy, an early method of PGA, has had favorable…”
Get full text

Prostate cancer risk stratification with magnetic resonance imaging by Felker, Ely R., M.D, Margolis, Daniel J., M.D, Nassiri, Nima, M.D, Marks, Leonard S., M.D

“…Abstract In recent years, multiparametric magnetic resonance imaging (mpMRI) has shown promise for prostate cancer (PCa) risk stratification. mpMRI, often…”
Get full text

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm by Priester, Alan, Mota, Sakina Mohammed, Grunden, Kyla P., Shubert, Joshua, Richardson, Shannon, Sisk, Anthony, Felker, Ely R., Sayre, James, Marks, Leonard S., Natarajan, Shyam, Brisbane, Wayne G.

“…Objective The objective of this study is to compare detection rates of extracapsular extension (ECE) of prostate cancer (PCa) using artificial intelligence…”
Get full text

Prediction and Mapping of Intraprostatic Tumor Extent with Artificial Intelligence by Priester, Alan, Fan, Richard E., Shubert, Joshua, Rusu, Mirabela, Vesal, Sulaiman, Shao, Wei, Khandwala, Yash Samir, Marks, Leonard S., Natarajan, Shyam, Sonn, Geoffrey A.

“…A multimodal artificial intelligence (AI) model, trained to estimate prostate cancer probability in three dimensions, was retrospectively validated using…”
Get full text

Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration by Loeb, Stacy, Sokoll, Lori J, Broyles, Dennis L, Bangma, Chris H, van Schaik, Ron H N, Klee, George G, Wei, John T, Sanda, Martin G, Partin, Alan W, Slawin, Kevin M, Marks, Leonard S, Mizrahi, Isaac A, Shin, Sanghyuk S, Cruz, Amabelle B, Chan, Daniel W, Roberts, William L, Catalona, William J

“…Reported prostate specific antigen values may differ substantially among assays using Hybritech® or WHO standardization. The Beckman Coulter® Prostate Health…”
Get more information

Targeted prostate biopsy： value of multiparametric magnetic resonance imaging in detection of localized cancer by Le, Jesse D, Huang, Jiaoti, Marks, Leonard S

“…Prostate cancer is the second most common cancer in men, with 1.1 million new cases worldwide reported by the World Health Organization in one recent year…”
Get full text